AML - Acute Myeloid Leukemia research hub
3 indexed studies · 3 currently recruiting
- not yet recruitingPHASE2
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
This study looks at two types of chemotherapy, Treosulfan and Melphalan, often given before a stem cell transplant for blood cancers like AML and MDS. We want to see which one works better and has fewer side effects for patients.
Germany - recruiting
WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment
This study looks at how a smartwatch can help doctors understand how people with blood cancers feel during treatment. It aims to improve quality of life and ensure blood transfusions are given when they're most needed, based on how active patients are.
United Kingdom - recruitingPHASE2
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
This study looks at combining a new drug, Gilteritinib, with standard treatments (Venetoclax and Azacitidine) for acute myeloid leukaemia (AML) in patients who have a specific gene change (FLT3 mutation) and can't have strong chemotherapy. It aims to find the safest and most effective dose.
Germany